The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
Q1 consolidated profit decline 90% year-on-year at Rs 126 crore due to the base effect.
Q4FY13 net profit at Rs 27.80 crore against loss of Rs 41.30 crore in the corresponding quarter of the previous financial year.
Q4FY13 same store sales growth at 7.7% against 16.1% in Q3FY13 and 46.1% in Q4FY12.
Q4 net profit at Rs 251 crore against an average analyst estimates of Rs 302 crore.
Weakness persists in Oil & gas, healthcare and metal spaces in noon deals
The broader markets gained with mid-caps and small-caps rising nearly 0.2% on the BSE.
Punjab National Bank and Union Bank of India has surged 5% each at Rs 788 and Rs 251 respectively on NSE.
The board has recommended a dividend of 80% or Rs 8 per share for the financial year 2012-13.
Gross NPA of the bank have come down from 4.61% at the end of Q3FY13 to 4.27% in the recently concluded quarter.
Q4 profit down 15% yoy at Rs 292 crore mainly due to higher staff cost.
BSE Healthcare, Capital Goods and Bankex indices have declined by nearly 1% each. However, BSE IT index has surged by 1%.
The board approved the proposal to sell the entire Chennai Project Division to Ceebros Hotels a total consideration of Rs 480 crore.
Markets were trading flat with a negative bias amid lack of buying support as investors turned cautious after recent gains
EBITDA margin expanded by 91bp yoy to 10.5% mainly due to reduction in raw material cost and other expenses as a percentage of sales.
The board will meet on May 13, to consider the proposal for buyback of shares.
Q1 net profit down 11% yoy at Rs 42.56 crore mainly due to higher interest cost.
investors turned cautious after gains in the past few sessions and ahead of key economic data due on Friday.
Q4 net profit at Rs 2.7 crore against loss of Rs 330 crore in year ago quarter.
Watch out for Lupin, HDFC, ABB and IT shares in trades today
The company said its antibiotic drug 'Elores' received tremendous response from medical fraternity.